Promoting Oral Health Among Smokers Randomized Trial

NCT02347124 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 718

Last updated 2019-10-08

Study results available
· View outcomes & findings →

Summary

The current study will test the effectiveness of a multi-modal behavioral intervention (the Oral Health 4 Life program) targeted to smokers who are ready to quit smoking and seeking services through tobacco quitlines.

The investigators hypothesize that, compared to people in the control arm, participants in the enhanced intervention will:

1. Be more likely to quit smoking as evidenced by 7 day point prevalent abstinence rates at 6 month follow-up \[primary outcome\] and at 2 month follow-up \[secondary outcome\].
2. Be more likely to see a dental care professional in the past 6 months at 6 month follow-up \[primary outcome\].
3. Exhibit more positive change in relevant oral health knowledge/beliefs and attitudes (e.g., self-efficacy, motivation) that could influence future behavior change.

Conditions

  • Oral Disease
  • Smoking

Interventions

BEHAVIORAL

Usual Care Control

Standard quitline counseling and other treatment materials provided through each participating state quitline program + a series of text messages with general health promotion tips.

BEHAVIORAL

Enhanced Intervention

Standard quitline counseling and other materials provided through each participating state quitline program + oral health-focused counseling + oral health focused text messages + access to additional oral health educational content (website and written materials) + oral health tools (toothbrush, dental floss)

Sponsors & Collaborators

  • Consumer Wellness Solutions

    collaborator INDUSTRY
  • University of California

    collaborator OTHER
  • National Institute of Dental and Craniofacial Research (NIDCR)

    collaborator NIH
  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Jennifer McClure, PhD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02347124 on ClinicalTrials.gov